Correlation Between Pharvaris and Premier Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Premier Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Premier Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Premier Biomedical, you can compare the effects of market volatilities on Pharvaris and Premier Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Premier Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Premier Biomedical.

Diversification Opportunities for Pharvaris and Premier Biomedical

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pharvaris and Premier is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Premier Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Premier Biomedical and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Premier Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Premier Biomedical has no effect on the direction of Pharvaris i.e., Pharvaris and Premier Biomedical go up and down completely randomly.

Pair Corralation between Pharvaris and Premier Biomedical

Given the investment horizon of 90 days Pharvaris BV is expected to generate 0.74 times more return on investment than Premier Biomedical. However, Pharvaris BV is 1.35 times less risky than Premier Biomedical. It trades about -0.07 of its potential returns per unit of risk. Premier Biomedical is currently generating about -0.06 per unit of risk. If you would invest  2,393  in Pharvaris BV on September 3, 2024 and sell it today you would lose (203.00) from holding Pharvaris BV or give up 8.48% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  Premier Biomedical

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
Premier Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Premier Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pharvaris and Premier Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and Premier Biomedical

The main advantage of trading using opposite Pharvaris and Premier Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Premier Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Premier Biomedical will offset losses from the drop in Premier Biomedical's long position.
The idea behind Pharvaris BV and Premier Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities